切换至 "中华医学电子期刊资源库"

中华普通外科学文献(电子版) ›› 2018, Vol. 12 ›› Issue (06) : 405 -408. doi: 10.3877/cma.j.issn.1674-0793.2018.06.009

所属专题: 文献

论著

血管内皮生长因子C对胃癌淋巴结转移及微转移的预测价值研究
邓庆炎1,(), 陈宏1, 雒洪志1, 张倩1   
  1. 1. 528400 广东省中山市人民医院普外三科
  • 收稿日期:2018-07-19 出版日期:2018-12-01
  • 通信作者: 邓庆炎

Predictive value of vascular endothelial growth factor C in lymph node metastasis and micrometastasis of gastric cancer

Qingyan Deng1,(), Hong Chen1, Hongzhi Luo1, Qian Zhang1   

  1. 1. The Third Department of GeneralSurgery, Zhongshan City People's Hospital, Zhongshan 528400, China
  • Received:2018-07-19 Published:2018-12-01
  • Corresponding author: Qingyan Deng
  • About author:
    Corresponding author: Deng Qingyan, Email:
引用本文:

邓庆炎, 陈宏, 雒洪志, 张倩. 血管内皮生长因子C对胃癌淋巴结转移及微转移的预测价值研究[J]. 中华普通外科学文献(电子版), 2018, 12(06): 405-408.

Qingyan Deng, Hong Chen, Hongzhi Luo, Qian Zhang. Predictive value of vascular endothelial growth factor C in lymph node metastasis and micrometastasis of gastric cancer[J]. Chinese Archives of General Surgery(Electronic Edition), 2018, 12(06): 405-408.

目的

分析胃癌患者血清中血管内皮生长因子C(VEGF-C)的表达情况及其与淋巴结微转移的关系,初步探讨VEGF-C对胃癌患者的临床价值。

方法

选择2012年1月至2016年1月间中山市人民医院行胃癌根治术的患者113例以及同期的健康成人志愿者30例,采用酶联免疫吸附技术(ELISA)检测胃癌患者及健康人群的血清VEGF-C的蛋白质量浓度;免疫组织化学染色法检测常规苏木精-伊红(HE)染色无淋巴结转移的患者淋巴结微转移情况;分析VEGF-C蛋白在血清的表达与患者临床病理资料以及淋巴结微转移之间的关系。

结果

113例胃癌患者的血清VEGF-C蛋白质量浓度为(1 687.06±305.21)ng/L,显著高于健康对照的(729.46±182.31)ng/L,差异有统计学意义(t=8.61,P<0.05)。淋巴结转移组66例患者的血清VEGF-C质量浓度为(2 063.75±313.08)ng/L,显著高于无淋巴结转移组47例的(1 208.39±231.92)ng/L,差异有统计学意义(t=7.23,P<0.05)。淋巴结微转移组15例共41枚的VEGF-C质量浓度为(1 306.01±265.69)ng/L,与无淋巴结微转移组32例(1 183.26±206.54)ng/L比较,差异无统计学意义(t=1.92,P>0.05)。不同TNM临床分期的胃癌患者VEGF-C表达水平差异有统计学意义(F=10.21,P<0.05)。以血清VEGF-C质量浓度1 705.60 ng/L为诊断界值,预测淋巴结转移的敏感度和特异度分别为77.3%和83.0%。

结论

血清VEGF-C浓度可作为胃癌的辅助诊断指标,检测血清VEGF-C浓度对术前预测胃癌淋巴结转移和提高术前临床分期的准确性有益。血清VEGF-C浓度与胃癌淋巴结微转移的相关性不大。

Objective

To investigate the expression of vascular endothelial growth factor (VEGF)-C in serum of patients with gastric carcinoma, and to analyze its relationship and clinicopathological features to predict the clinical value of lymph node metastasis and micrometastasis.

Methods

Between January 2012 and January 2016, a total of one hundred and thirteen patients with gastric carcinoma and 30 healthycontrols were studied. Serum VEGF-C levels were assessed by enzymed-linked immunosorbent assay (ELISA). The negative lymph nodes examined by hematoxylin-eosin (HE) staining were analyzed by immunohistochemical staining (IHC) for micrometastasis. Statistical analysis was done to explore the relationship between the expression of VEGF-C protein in serum and clinicopathological data and lymph nodemicrometastasis.

Results

The serum level of VEGF-C protein in patients with gastric cancer was (1 687.06±305.21) ng/L, which was significantly higher than that in healthy controls (729.46±182.31) ng/L (t=8.61, P<0.05). The concentration of VEGF-C in serum of 66 patients with lymph node metastasis was (2 063.75±313.08) ng/L, significantly higher than (1 208.39±231.92) ng/L in 47 patients without lymph node metastasis, the difference was statistically significant (t=7.23, P<0.05). There was no significant difference in the concentration of VEGF-C between micrometastasis group and non-micrometastasis group [(1 306.01±265.69) ng/L vs (1 183.26±206.54) ng/L, t=1.92, P>0.05]. The expression of VEGF-C in gastric cancerpatients with different TNM clinical stages was significantly different (F=10.21, P<0.05). The sensitivity and specificity of predicting lymph node metastasis were 77.3% and 83.0% respectively with serum VEGF-C concentration of 1 705.60 ng/L as the diagnostic threshold.

Conclusions

The serum levels of VEGF-C have potential use as diagnostic measurements in gastric carcinoma. Detection of serum VEGF-C concentration is helpful to predict lymph node metastasis and improve the accuracy of preoperative clinical staging of gastric cancer. There is no relationship between serum VEGF-C level and lymph node micrometastasis.

表1 VEGF-C蛋白表达与113例胃癌患者临床病理特征的关系(ng/L,±s
图1 淋巴结中的CK-20阴性(SP染色 ×400)
图2 淋巴结中的CK-20阳性(SP染色 ×400)
图3 ROC曲线分析患者血清VEGF-C浓度水平预测淋巴结转移的价值 曲线下面积为0.863(95% CI=0.792~0.933)
[1]
Joukov V, Pajusola K, Kaipainen A, et al. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases[J]. EMBO J, 1996, 15(2): 290-298.
[2]
Yanai Y, Furuhata T, Kimura Y, et al. Vascular endothelial growth factor C promotes human gastric carcinoma lymph node metastasis in mice[J]. J Exp Clin Cancer Res, 2001, 20(3): 419-428.
[3]
李涛,王云海,何铁汉, 等. IHC和RT-PCR法对检测胃癌区域淋巴结微转移的价值及其意义[J]. 中国普通外科杂志, 2009, 18(4): 322-325.
[4]
Jeltsch M, Kaipainen A, Joukov V, et al. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice[J]. Science, 1997, 276(5317): 1423-1425.
[5]
Cao Y. Opinion: emerging mechanisms of tumour lymphangiogenesis and lymphatic metastasis[J]. Nat Rev Cancer, 2005, 5(9): 735-743.
[6]
Rauniyar K, Jha SK, Jeltsch M. Biology of vascular endothelial growth factor C in the morphogenesis of lymphatic vessels[J]. Front Bioeng Biotechnol, 2018, 6: 7.
[7]
Yu P, Wu G, Lee HW, et al. Endothelial metabolic control of lymphangiogenesis[J]. Bioessays, 2018, 40(6): e1700245.
[8]
Onogawa S, Kitadai Y, Amioka T, et al. Expression of vascular endothelial growth factor (VEGF)-C and VEGF-D in early gastric carcinoma: correlation with clinicopathological parameters[J]. Cancer Lett, 2005, 226(1): 85-90.
[9]
Ding S, Li C, Lin S, et al. Distinct roles of VEGF-A and VEGF-C in tumour metastasis of gastric carcinoma[J]. Oncol Rep, 2007, 17(2): 369-375.
[10]
Shida A, Fujioka S, Kobayashi K, et al. Expression of vascular endothelial growth factor (VEGF)-C and -D in gastric carcinoma[J]. Int J Clin Oncol, 2006, 11(1): 38-43.
[11]
陈宏,余元龙,邓庆炎, 等. 胃癌中血管内皮生长C的表达与淋巴结微转移的关系[J/CD]. 中华普通外科学文献(电子版), 2011, 5(5): 413-417.
[12]
吴泽宇. 胃癌淋巴结微转移的研究进展[J]. 中华胃肠外科杂志, 2005, 8(3): 275-277.
[13]
Cai J, Ikeguchi M, Maeta M, et al. Micrometastasis in lymph nodes and microinvasion of the muscularis propria in primary lesions of submucosal gastric cancer[J]. Surgery, 2000, 127(1): 32-39.
[1] 李越洲, 张孔玺, 李小红, 商中华. 基于生物信息学分析胃癌中PUM的预后意义[J]. 中华普通外科学文献(电子版), 2023, 17(06): 426-432.
[2] 张俊, 罗再, 段茗玉, 裘正军, 黄陈. 胃癌预后预测模型的研究进展[J]. 中华普通外科学文献(电子版), 2023, 17(06): 456-461.
[3] 闫笑生, 郑智, 翟育豪, 张海翘, 王鈢, 刘小野, 尹杰, 张军. Borrmann Ⅳ型胃癌临床诊断、病理特征及预后分析[J]. 中华普通外科学文献(电子版), 2023, 17(05): 346-351.
[4] 王龙彪, 刘洪, 董天雄. 中心体扩增细胞占比和C反应蛋白-白蛋白比值对胃癌根治术治疗预后的预测价值[J]. 中华普通外科学文献(电子版), 2023, 17(05): 352-356.
[5] 韩晓帆, 段降龙, 付小庆, 马文星, 王泽正, 刘哲魁. 老年胃癌根治性全胃切除术围手术期并发症的危险因素分析[J]. 中华普通外科学文献(电子版), 2023, 17(04): 282-287.
[6] 朱磊磊, 朱冰, 管佳佳, 骆杰, 杭群, 傅军. 血浆PAX5、SEPT9和WIF-1基因启动子甲基化在原发性胃癌中的诊断价值[J]. 中华普通外科学文献(电子版), 2023, 17(04): 288-292.
[7] 莫波, 王佩, 王恒, 何志军, 梁俊, 郝志楠. 腹腔镜胃癌根治术与改良胃癌根治术治疗早期胃癌的疗效[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 644-647.
[8] 陈大敏, 曹晓刚, 曹能琦. 肥胖对胃癌患者手术治疗效果的影响研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 651-653.
[9] 王鸿彬, 何晓, 吴菁宙. 腹腔镜近端胃切除术中背驮式间置空肠单通道重建术在AEG手术的安全性及抗反流效果研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(05): 526-529.
[10] 宋钰, 赵阳, 王惠君, 廖新华. 术前BMI与可切除胃癌患者术后远期生存的关系[J]. 中华普外科手术学杂志(电子版), 2023, 17(05): 530-533.
[11] 高静, 严学倩, 及月茹, 郝淼旺, 刘苍春. 胃癌患者以慢性贫血为首发表现的高危因素Logistic分析[J]. 中华普外科手术学杂志(电子版), 2023, 17(05): 534-537.
[12] 张彬, 贾贵清, 吴东松, 曹绿洲, 张焰凌, 黄灏, 赵高平. 早期胃癌保功能手术治疗13例病例分析[J]. 中华普外科手术学杂志(电子版), 2023, 17(05): 575-579.
[13] 徐瑜杰, 赵国栋. 晚期胃癌治疗方法的研究进展和挑战[J]. 中华普外科手术学杂志(电子版), 2023, 17(04): 451-455.
[14] 黄勇, 郑智, 张海翘, 王龙, 辛城霖, 刘小野, 尹杰, 张军. 近端胃切除术后消化道重建方式的研究进展[J]. 中华普外科手术学杂志(电子版), 2023, 17(04): 456-460.
[15] 季加孚, 苏昊, 季科. 不断推进中国腹腔镜胃癌外科手术规范化[J]. 中华普外科手术学杂志(电子版), 2023, 17(04): 355-359.
阅读次数
全文


摘要